“Through its patient-data-derived Gemini digital twins, Aitia is uncovering the hidden genetic and molecular mechanisms that causally drive human disease, and accelerating the discovery of breakthrough drugs to improve outcomes for neurodegenerative disorders and cancer.”
Read the article here.